511 related articles for article (PubMed ID: 19076962)
1. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla.
Booth SJ; Pickles MD; Turnbull LW
BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962
[TBL] [Abstract][Full Text] [Related]
2. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
3. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
Booth SJ; Turnbull LW; Poole DR; Richmond I
BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
[TBL] [Abstract][Full Text] [Related]
4. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration.
Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM
NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245
[TBL] [Abstract][Full Text] [Related]
5. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
6. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.
Canese R; Pisanu ME; Mezzanzanica D; Ricci A; Paris L; Bagnoli M; Valeri B; Spada M; Venditti M; Cesolini A; Rodomonte A; Giannini M; Canevari S; Podo F; Iorio E
NMR Biomed; 2012 Apr; 25(4):632-42. PubMed ID: 22020805
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry in gynaecological pathology: a review.
Marjoniemi VM
Pathology; 2004 Apr; 36(2):109-19. PubMed ID: 15203746
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
[TBL] [Abstract][Full Text] [Related]
10. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla.
Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C
Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification.
Lee CW; Lee JH; Kim DH; Min HS; Park BK; Cho HS; Kang HG; Suh JS; Ehara S
Clin Imaging; 2010; 34(1):47-52. PubMed ID: 20122519
[TBL] [Abstract][Full Text] [Related]
13. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy of premalignant and malignant endometrial disorders: a feasibility of in vivo study.
Celik O; Hascalik S; Sarac K; Meydanli MM; Alkan A; Mizrak B
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):241-5. PubMed ID: 15653212
[TBL] [Abstract][Full Text] [Related]
15. [1H magnetic resonance spectroscopy of the prostate].
Mueller-Lisse UG; Scherr M
Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
[TBL] [Abstract][Full Text] [Related]
16. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
[TBL] [Abstract][Full Text] [Related]
17. Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31)P magic angle spinning MRS of intact tissue.
De Silva SS; Payne GS; Thomas V; Carter PG; Ind TE; deSouza NM
NMR Biomed; 2009 Feb; 22(2):191-8. PubMed ID: 18833545
[TBL] [Abstract][Full Text] [Related]
18. In vivo detection of choline in ovarian tumors using 3D magnetic resonance spectroscopy.
Esseridou A; Di Leo G; Sconfienza LM; Caldiera V; Raspagliesi F; Grijuela B; Hanozet F; Podo F; Sardanelli F
Invest Radiol; 2011 Jun; 46(6):377-82. PubMed ID: 21467947
[TBL] [Abstract][Full Text] [Related]
19. Preinvasive and invasive cervical cancer: an ex vivo proton magic angle spinning magnetic resonance spectroscopy study.
Mahon MM; deSouza NM; Dina R; Soutter WP; McIndoe GA; Williams AD; Cox IJ
NMR Biomed; 2004 May; 17(3):144-53. PubMed ID: 15137039
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of choline measurement by proton MR spectroscopy in patients with malignant tumors.
Lee J; Yamaguchi T; Abe A; Shizukuishi K; Uemura H; Miyagi E; Sakata K; Inoue T
Radiat Med; 2004; 22(3):148-54. PubMed ID: 15287529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]